Immunic (IMUX) announced that IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6, demonstrated a ...
Black Cat Syndicate (BC8), Biome Australia (BIO), Botanix Pharma (BOT), Genesis Minerals (GMD, Meeka Metals (MEK), Megaport ...
The S&P/ASX 200 closed 61.8 points lower, down 0.73%. Disappointing results from National Australia Bank (NAB) and iron ore, ...
Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.